Terveystalo's ARC Pivot: Trading Margin Protection for Growth in a Sticky Occupational Health Market

The Finnish healthcare group cuts guidance again but bets on consumer demand, fixed-price products, and M&A — while connected employees stay flat until 2027.

TTALO.HE · Earnings Call · 2026-07-17

The Occupational Health Drag

Terveystalo's second quarter came in "as difficult as expected," but the report's deeper significance is a deliberate strategic pivot rather than a routine miss. Full-year adjusted operating profit guidance was cut to EUR 120-140 million from EUR 156 million in 2025, and CEO Ville Iho is explicit that two factors drove the change: Q2 underperformance and a stickier-than-expected occupational health market. “It's both. Obviously, we are trailing during Q2 slightly against our targets... the stickiness of the occupational healthcare market.” — Ville Iho, President and CEO · 2026-07-17 The crux is connected employees. They have stabilized — flat from Q1 to Q2 — but are not growing, and management now expects meaningful wins to land in 2027, not the second half. CFO Juuso Pajunen was blunt that a solid sales pipeline has not converted into revenue-generating contracts fast enough. This marks a tonal shift from the prior call, when Iho pointed to "a clear improvement in the new opportunities funnel" and “deals are won and equally lost all the time” — Ville Iho, CEO · 2026-04-24, implying second-half growth was within reach. By Q2, those conversions simply hadn't materialized into the numbers, and the inflection has slipped to next year.

The ARC Pivot Bets on Growth

If occupational health is the bad news, the strategic shift is the real news. The newly unveiled ARC strategy explicitly reweights the company toward growth rather than protecting profitability — a notable departure from its earlier insistence that both could be had. In late 2025, Iho had been adamant: “it is not going to be either or, so either volume or profitability. It's going to be both going forward.” — Ville Iho, Chief Executive Officer (CEO) · 2025-10-23 Now the framing is unmistakably growth-first, anchored by the Silmäasema acquisition, which management says will create a EUR 1.5 billion outpatient care masterclass and a two-million-customer base for cross-selling and loyalty programs. At the product level, the company is scaling fixed price packages, targeting the "uncertainty around what do you pay for, what do you get" barrier rather than the sticker price itself. Notably, management rejects fully fixed-price corporate contracts — "The experiences from both clients and our suppliers are not great" — but embraces fixed packages for consumer services like health checks and joint replacements, where it has already seen a measurable demand-stimulation effect.

When we are talking about fixed packages, we are talking about consumer products. Be it health check or joint replacement or that type of clear packages that are clearly priced, easy to buy, easy to understand what you are getting.
Ville Iho, President and CEO · 2026-07-17

Glimmers of Light

Beneath the drag, real positives exist. The consumer market picked up as the quarter progressed, with visit frequency above prior-year levels by June. Sweden — historically a drag — is showing the first genuine turnaround signs: “already, since the end of the previous year, we have been net positive in winning” — Juuso Pajunen, CFO and host of the earnings call · 2026-07-17 contracts. Dental, boosted by the pending Hohde acquisition, is gaining market share in both revenue and visits. The balance sheet supports the pivot: operating cash flow reached EUR 175 million over twelve months, and the company secured EUR 550 million in committed bank financing plus expanded revolving credit facilities for the acquisitions. Still, leverage sits at 2.5x net debt to adjusted EBITDA, near the top of the comfortable range, and the guidance midpoint implies second-half performance broadly in line with a year ago — relying on a return of upper respiratory disease to long term averages and a gradual consumer pickup, not a connected-employee breakthrough. At its heart, the message is patient: growth will come, but occupational health is "slowly turning a sticky business model." Terveystalo is betting it can ride the consumer wave and M&A scale into a more balanced, less cyclical machine — while the market waits to see whether the promised operating leverage finally pays off.